Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Device therapy: Who may and who may not benefit from an ICD?

Literature DB >> 21079640

Device therapy: Who may and who may not benefit from an ICD?

Arnold Pinter, Paul Dorian.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 21079640 DOI： 10.1038/nrcardio.2010.183

Source DB: PubMed Journal: Nat Rev Cardiol ISSN： 1759-5002 Impact factor: 32.419

× No keyword cloud information.

10 in total

1. Effective and efficient use of implantable defibrillators: sometimes it's over when it's over.

Authors: Paul Dorian
Journal: CMAJ Date: 2009-03-17 Impact factor: 8.262

2. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors: Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal: Circulation Date: 2008-05-15 Impact factor: 29.690

3. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245

4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245

Review 5. Sudden cardiac death: exploring the limits of our knowledge.

Authors: R J Myerburg
Journal: J Cardiovasc Electrophysiol Date: 2001-03

6. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.

Authors: Ilan Goldenberg; John Gillespie; Arthur J Moss; W Jackson Hall; Helmut Klein; Scott McNitt; Mary W Brown; Iwona Cygankiewicz; Wojciech Zareba
Journal: Circulation Date: 2010-09-13 Impact factor: 29.690

7. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.

Authors: Peter J Schwartz; Carla Spazzolini; Silvia G Priori; Lia Crotti; Alessandro Vicentini; Maurizio Landolina; Maurizio Gasparini; Arthur A M Wilde; Reinoud E Knops; Isabelle Denjoy; Lauri Toivonen; Gerold Mönnig; Majid Al-Fayyadh; Luc Jordaens; Martin Borggrefe; Christina Holmgren; Pedro Brugada; Luc De Roy; Stefan H Hohnloser; Paul A Brink
Journal: Circulation Date: 2010-09-13 Impact factor: 29.690

8. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.

Authors: Domenico Corrado; Hugh Calkins; Mark S Link; Loira Leoni; Stefano Favale; Michela Bevilacqua; Cristina Basso; Deirdre Ward; Giuseppe Boriani; Renato Ricci; Jonathan P Piccini; Darshan Dalal; Massimo Santini; Gianfranco Buja; Sabino Iliceto; N A Mark Estes; Thomas Wichter; William J McKenna; Gaetano Thiene; Frank I Marcus
Journal: Circulation Date: 2010-09-07 Impact factor: 29.690

9. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Authors: Kenneth A Ellenbogen; Joseph H Levine; Ronald D Berger; James P Daubert; Stephen L Winters; Eugene Greenstein; Alaa Shalaby; Andi Schaechter; Haris Subacius; Alan Kadish
Journal: Circulation Date: 2006-02-06 Impact factor: 29.690

10. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

Authors: Douglas L Packer; Jordan M Prutkin; Anne S Hellkamp; L Brent Mitchell; Robert C Bernstein; Freda Wood; John P Boehmer; Mark D Carlson; Robert P Frantz; Steve E McNulty; Joseph G Rogers; Jill Anderson; George W Johnson; Mary Norine Walsh; Jeanne E Poole; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal: Circulation Date: 2009-11-16 Impact factor: 29.690

10 in total

1 in total

Review 1. Effective communication and ethical consent in decisions related to ICDs.

Authors: Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal: Nat Rev Cardiol Date: 2011-07-26 Impact factor: 32.419

1 in total